Search the Newsreel

Precigen COO Rutul Shah sells $219,518 in company stock

Precigen's COO, Rutul R. Shah, sold 33,772 shares of common stock for $219,518 at $6.50 per share on August 3, 2026, while simultaneously acquiring the same number of shares for $78,688 through stock option exercise. Following these transactions, Shah holds 497,751 direct shares and …

PGEN (PGEN) shareholder Rutul Shah files to sell 33,772 common shares

Rutul Shah, a shareholder of Precigen, Inc. (PGEN), has filed a Form 144 to sell 33,772 common shares. The proposed sale, valued at $219,518.00, will occur on or after August 3, 2026, via Fidelity Brokerage Services LLC on NASDAQ. These shares were acquired through …

PepGen Inc expected to post a loss of 29 cents a share - Earnings Preview

PepGen Inc is projected to report a loss of 29 cents per share. This information is provided as an earnings preview by Reuters, accessible via TradingView News.

Precigen, Inc. Revenue Breakdown – NASDAQ:PGEN

Precigen Insider Sold Shares Worth $606,000, According to a Recent SEC Filing

An insider at Precigen, Inc. sold shares valued at $606,000, as reported in a recent SEC filing. This transaction follows other recent insider share sales by the company, including sales worth $1,113,143 and $2,042,864 in early July. Precigen is a biopharmaceutical company focused on …

Precigen (NASDAQ: PGEN) CFO sells 100,000 shares in 10b5-1 plan

Precigen's Chief Financial Officer, Harry Thomasian Jr., sold 100,000 shares of common stock on July 31, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $6.06, totaling approximately $606,000. Following this transaction, Thomasian Jr. directly holds …

PGEN (PGEN) insider outlines planned sale of 100,000 common shares

Harry Thomasian Jr., an insider at Precigen, Inc. (PGEN), has announced plans to sell 100,000 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $605,609.66. These shares are related to restricted stock vesting on August 28, 2024. This …

Precigen Inc (PGEN) Institutional Confidence

Precigen Inc's institutional confidence score is 7.00, ranking 50th out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion increased by 12.24% quarter-over-quarter, reaching 75.82%. Steven Cohen is the largest institutional shareholder, holding 5.84 million shares, representing 1.87% of shares outstanding.

PGEN|Precigen Inc|Price:5.950|Chg%:+0.500

TradingKey provides a comprehensive stock analysis of Precigen Inc (PGEN), highlighting its stable fundamentals, high growth potential, and fair valuation. The company's revenue has grown significantly, and it boasts high institutional ownership, with multiple analysts rating it a "Buy." Despite some technical indicators suggesting …

Earnings Preview: Precigen to Report Financial Results Post-market on August 04

This article announces that Precigen (PGEN) is scheduled to report its financial results after market close on August 4, 2026. The report will cover the company's performance and is an anticipated event for investors and analysts following the company.

PepGen Inc. Revenue Breakdown – NASDAQ:PEPG

This article provides a brief overview of PepGen Inc.'s revenue breakdown as listed on NASDAQ under the ticker PEPG. It highlights where to find financial information, including segments and regional performance data, through the TradingView platform. The content primarily focuses on navigation within TradingView …

PepGen (PEPG) to Post Quarterly Earnings on Thursday

PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of PepGen Inc (PEPG), detailing its support, resistance, indicators, and moving averages. It summarizes various technical indicators such as MACD, RSI, and CCI, along with moving averages (MA5 to MA200), to offer a comprehensive overview of the stock's …

Precigen (PGEN) Projected to Release Earnings on Tuesday

Precigen Inc (PGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Precigen Inc (PGEN) regarding its dividend history and stock splits. It states that the company has distributed a total of $0.00 in dividends over the past five years, indicating no recent dividend payouts. The page also presents basic …

PepGen Inc (PEPG) Cash Flow

This article provides a detailed cash flow statement for PepGen Inc (PEPG), covering quarterly data from FY2020Q3 to FY2026Q1. It breaks down operating, investing, and financing cash flows, along with changes in working capital and overall cash balances. The document also includes an FAQ …

Recover Investment Losses: Levi & Korsinsky Files Class Action Against PepGen Inc. (PEPG)

Levi & Korsinsky LLP has filed a class action securities lawsuit against PepGen Inc. (NASDAQ: PEPG) on behalf of investors who suffered losses due to alleged securities fraud between March 7, 2024, and March 3, 2025. The lawsuit claims that PepGen made false and …

PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for PepGen Inc (PEPG), detailing its volatility, financial risk, and investment risk. It includes key metrics such as Beta, VaR, Maximum Drawdown, Realized Volatility, and daily return percentages over various periods. The report also covers aspects like Sharpe …

Precigen Inc Revenue Breakdown – GETTEX:I5X

This article provides a revenue breakdown for Precigen Inc (GETTEX:I5X), detailing its top-performing segment and geographical contributions. Last year, the company generated 8.25M EUR, with the Exemplar segment contributing 3.79M EUR and the United States accounting for all of the revenue.

PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings

The article provides a detailed breakdown of PepGen Inc's (PEPG) shareholder structure, listing major shareholders and their proportions, as well as categorizing shareholder types. It also presents institutional shareholding data over several quarters and highlights recent shareholder activity, including changes in holdings.

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th

Precigen, Inc. (Nasdaq: PGEN) will release its full-year 2024 financial results and provide business updates on Wednesday, March 19, 2025. The biopharmaceutical company will host a conference call on the same day at 4:30 PM ET to discuss the results. Precigen specializes in developing …

Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company, announced that it will release its second quarter 2026 financial results and provide business updates on Tuesday, August 4, 2026. The company will host a conference call at 4:30 PM ET on that day to discuss the …

Precigen (PGEN) to Release Q2 Financial Results and Discuss Business Progress

Precigen (PGEN) will announce its Q2 financial results on August 4, 2026, and hold a conference call to discuss business developments, including the recent FDA approval of PAPZIMEOS. The company reported a significant revenue increase in Q1 2026 due to PAPZIMEOS sales, leading to …

Precigen sets 4:30 p.m. ET call for Aug. 4 business update

Precigen (Nasdaq: PGEN) announced it will release its second quarter 2026 financial results and provide business updates on Tuesday, August 4, 2026. A conference call to discuss the results will be held at 4:30 PM ET, and details are available on the company’s investor …

ETFs Investing in Precigen Inc Stocks

This article provides a list of Exchange Traded Funds (ETFs) that hold shares of Precigen Inc. (PGEN), detailing each fund's market value, Precigen Inc. stock weight, issuer, management style, focus, expense ratio, AUM, price, change, and 3-year NAV total return. The ETFs cover various …

Precigen (PGEN) Proxy Filing Summary

Precigen's upcoming annual meeting on June 26, 2025, will address director elections, an increase in authorized common stock, approval of Series A Preferred Stock and Warrants issuance to Randal J. Kirk, auditor ratification, executive compensation, and amendments to equity incentive plans. The Board recommends …

What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?

Precigen CFO Harry Thomasian Jr. sold 200,000 shares for $1.1 million, reducing his direct ownership by 36% through a pre-arranged Rule 10b5-1 trading plan. This sale, occurring when shares hit a multi-year high, is not considered a red flag for investors due to the …